Journal profile · SUBSTANCE ABUSE
Substance Use-Research and Treatment
ISSN 2976-8357 · SAGE
Substance Use-Research and Treatment: CAS Zone 3 · Medicine (2026 Xinrui edition); hybrid open access; median 109 days to acceptance (66 articles, last 24 months); 32 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Substance Use-Research and Treatment is published by SAGE and is classed under Medicine in the CAS Journal Ranking. By OpenAlex counts of its recent articles, its largest topics are Substance Abuse Treatment and Outcomes, Opioid Use Disorder Treatment and HIV, Drug Use, Sexual Risk, together about 62.2% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): SUBSTANCE ABUSE
Main research topics OpenAlex counts of recent articles; shares are approximate
- Substance Abuse Treatment and OutcomesMedicine33.9%
- Opioid Use Disorder TreatmentMedicine22.2%
- HIV, Drug Use, Sexual RiskMedicine6.1%
- Mental Health Treatment and AccessPsychology5.7%
- Smoking Behavior and CessationMedicine4.8%
- Youth, Drugs, and ViolenceSocial Sciences3%
- Alcohol Consumption and Health EffectsMedicine2.6%
- Forensic Toxicology and Drug AnalysisPharmacology, Toxicology and Pharmaceutics2.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Substance Abuse | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Medicine (miscellaneous) | Q2 | 119/466 | 74th |
| Psychiatry and Mental Health | Q2 | 187/580 | 67th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 5LetPub ·
- SJR 2026-06
- 0.97LetPub ·
- SNIP 2026-06
- 1.44LetPub ·
- h-index
- 5OpenAlex ·
- i10-index
- 2OpenAlex ·
- 2-year mean citedness
- 1.22OpenAlex ·
- Self-citation rate
- 5.6%LetPub ·
- Share of gold OA articles
- 92.59%LetPub ·
Volume
- Articles per year
- 31LetPub ·
Articles by year OpenAlex count · 96 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 40 | 40 | 63 |
| 2025 | 32 | 32 | 46 |
| 2024 | 24 | 24 | 8 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
109 daysMedian, submission to acceptance · P25–P75 85 days – 144 days
- Acceptance to online
- median 30 days (66 articles)
- Submission to online
- median 146 days
- Sample
- 66 articles with submission and acceptance dates (70 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- SAGE
- ISSN
- 2976-8357
FAQ
Frequently asked questions about Substance Use-Research and Treatment
What CAS zone is Substance Use-Research and Treatment in?
In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Substance Use-Research and Treatment?
Based on the dates recorded on 66 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 109 days (interquartile range 85–144 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Substance Use-Research and Treatment?
According to LetPub and DOAJ records, Substance Use-Research and Treatment is indexed in ESCI and Scopus.
Is Substance Use-Research and Treatment open access, and what is the APC?
Substance Use-Research and Treatment is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .